Related Experiment Video
Updated: May 13, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Colorectal surveillance in Lynch syndrome families
Wouter H de Vos tot Nederveen Cappel1, Heikki J Järvinen, Patrick M Lynch
1Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, The Netherlands. w.h.de.vos@isala.nl
Abstract:
Lynch syndrome (LS) is an autosomal dominant disorder caused by a mutation in one of the mismatch repair genes. Mutation carriers have a life-time risk of developing colorectal cancer (CRC) of between 25 and 75 %. Since the importance of a centralized organization of surveillance was emphasized in the late 1980s, the number of registered LS families with a known mutation has increased enormously worldwide. Large-scale surveillance programs of these families have achieved a 62 % reduction in incidence of CRC and a 65-70 % decrease in mortality. Nevertheless, the risk of CRC is still substantial even when included in a program and the most optimal surveillance interval for gene carriers remains unknown. Hopefully, improvements in high quality colonoscopy and new endoscopic visualization techniques will further reduce CRC risk in those included in a surveillance program.
